U.S. Chemicals Stock News

In late May 2026, Gilead Sciences reported positive Phase 3 data for Livdelzi in primary biliary cholangitis, secured accelerated FDA approval for Hepcludex as the first U.S. treatment for chronic hepatitis delta, and received a favorable European regulatory opinion expanding Trodelvy’s use in metastatic triple-negative breast cancer. Together, these liver and oncology milestones highlight Gilead’s growing presence in complex specialty diseases where few effective treatment options exist...

Recent price performance and business snapshot ZTO Express (Cayman) (ZTO) has drawn investor attention after recent share price weakness, with the stock down about 12% over the past month and roughly 5% over the past 3 months. The China based express delivery company, listed in the US, reports annual revenue of CN¥51,489.6m and net income of CN¥9,205.7m, mainly from trucking transportation and logistics services within the People's Republic of China. See our latest analysis for ZTO Express...

Recent share performance and business snapshot Insight Enterprises (NSIT) has drawn attention after a strong month for the stock, with a return of about 46%. The company reported revenue of US$8.27b and net income of US$179.84m from its global IT solutions business. See our latest analysis for Insight Enterprises. The recent 30 day share price return of 46.19% and 7 day gain of 8.85% suggest momentum has picked up, even though the 1 year total shareholder return declined 17.32% and the 3 year...

In late May 2026, lululemon athletica inc. and founder Dennis “Chip” Wilson reached a Cooperation Agreement that ends their proxy dispute, adds two of Wilson’s nominees to the board after the 2026 annual meeting, and commits to appointing a third independent director with apparel expertise by October 1, 2026, while supporting a move to annual director elections from 2028. This truce reduces governance friction during a leadership transition and may help the refreshed board and management...

Warby Parker (WRBY) has moved beyond traditional eyewear with the announcement of its first Intelligent Eyewear frames, developed with Google and Samsung. This development is putting fresh attention on how this new category could influence the stock. See our latest analysis for Warby Parker. Despite the Intelligent Eyewear launch and an upcoming appearance at the Baird Global Consumer, Technology & Services Conference, the stock has been choppy, with the share price down 4.67% over one day...

Avis Budget Group recently announced a US$300,000,000 offering of 8.000% senior unsecured notes due 2031 and appointed longtime insider Tina Goldenberg as Chief Accounting Officer, effective June 15, 2026, following Cathleen DeGenova’s retirement. The combination of a sizable new debt issue and a leadership transition at the core finance function highlights how Avis is refining both its capital structure and financial oversight. We’ll now examine how the new US$300,000,000, 8.000% notes...

Market context after earnings and expansion update BJ's Wholesale Club Holdings (BJ) has been in focus after first quarter results topped Wall Street expectations on revenue and profit, and the company announced plans for 12 new clubs in 2026 across multiple states. See our latest analysis for BJ's Wholesale Club Holdings. Even with the strong first quarter beat and fresh expansion plans, BJ's share price has softened, with a 30 day share price return down 8.8% and a 1 year total shareholder...

StoneX Group Inc. recently detailed the continued expansion of its Birmingham, Alabama office, a 46,000-square-foot hub housing securities clearing, core operational infrastructure, and wealth-related activities, with capacity for 310 seats and plans to add nearly 90 employees over the next three to five years. This build-out deepens StoneX’s long-standing operational roots in Birmingham, extending the legacy of Sterne Agee while tapping into the region’s growing financial talent...

The Marzetti Company has declared a quarterly dividend of US$1.00 per share, payable on June 30, 2026, to shareholders of record as of the June 5, 2026 ex-dividend date. At the same time, law firm Kirby McInerney LLP has begun investigating Marzetti and its leadership for potential securities law violations following disclosures of weaker Retail segment net sales and volumes. We’ll now examine how the new dividend alongside the securities law investigation could reshape Marzetti’s investment...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

In May 2026, Enphase Energy announced the rollout of its PowerMatch technology for IQ Battery 10C and 5P systems across the United States, Puerto Rico, much of North America, and select Central American and Caribbean markets, aiming to better align battery output with real-time household power needs. By selectively activating embedded microinverters to cut idle conversion losses and potentially lower homeowners’ lifetime energy costs, PowerMatch deepens Enphase’s push into more efficient,...

In May 2026, Google Research and Synaptics showcased the new Synaptics Coralboard at Google I/O, highlighting a compact, multimodal Edge AI development platform powered by the Astra SL2619 SoC, Torq NPU, and Coral NPU technology to accelerate real-world on-device AI prototyping. An unusual live installation, “Jellectronica,” turned jellyfish motion into AI-generated music using Coralboard and Google DeepMind’s Lyria Realtime model, underscoring how Synaptics’ Edge AI hardware and toolchain...

Earlier in 2026, Praxis Precision Medicines reported that the FDA accepted New Drug Applications for ulixacaltamide in essential tremor and relutrigine in developmental and epileptic encephalopathies, with target action dates in 2027 and key clinical readouts for other assets expected later in 2026. This twin NDA acceptance marks a major regulatory inflection for Praxis, elevating its late-stage CNS portfolio from purely clinical-stage potential to nearer-term commercialization...

In May 2026, Park National Corporation filed a US$253.13 million shelf registration to offer up to 1,500,000 common shares tied to its Employee Stock Ownership Plan. This ESOP-related shelf registration highlights the bank’s ongoing focus on employee ownership, while also introducing the possibility of future share dilution. We will now examine how this ESOP-related shelf registration shapes Park National’s investment narrative, particularly around capital flexibility and dilution...

Stock performance snapshot and context PG&E (PCG) has seen mixed share performance recently, with the stock roughly flat over the past month and down over the past 3 months, keeping investor attention on how current pricing lines up with fundamentals. See our latest analysis for PG&E. Looking beyond the recent pullback, PG&E’s share price has been roughly flat year to date, while the 1 year total shareholder return is slightly down and the 5 year total shareholder return is positive. This...

Stock slide puts Ladder Capital under closer scrutiny The recent slide in Ladder Capital (LADR) to around $10.22, alongside softer quarterly results, has put the real estate lender’s fundamentals under closer scrutiny for investors assessing income and value opportunities. See our latest analysis for Ladder Capital. While the 1-day and 7-day share price returns have been slightly positive, the year-to-date share price return is down 7.93%. However, the 1-year and 3-year total shareholder...

On May 19, 2026, Live Oak Bancshares’ board declared cash dividends on both its common shares and 8.375% Series A preferred stock, while also filing a US$121.97 million shelf registration for up to 3,350,000 common shares tied to its employee stock ownership plan. This combination of capital return and potential equity issuance highlights how Live Oak Bancshares is balancing shareholder distributions with plans to support employee ownership and future funding flexibility. We’ll now examine...

Popular stock triggered by recent performance trends Popular (BPOP) has attracted fresh attention after a period in which the stock rose about 46% over the past year and about 163% over the past 3 years, alongside positive annual revenue and net income growth. See our latest analysis for Popular. Short term share price returns for Popular have eased slightly, with the stock down around 1% over the past week, but the 1-year total shareholder return of 46.16% and 3-year total shareholder return...

In May 2026, Roivant Sciences reported fourth-quarter sales of US$2.52 million with net income of US$302.99 million, alongside a full-year net loss of US$299.77 million on US$8.26 million in sales. On the same day, the company filed a nearly US$981.62 million shelf registration for up to 34,796,916 common shares tied to employee stock plans, highlighting both recent profitability at the quarter level and potential future dilution. Next, we’ll examine how the sharp quarterly swing to...

Relay Therapeutics (RLAY) recently shared new Phase 2 data on zovegalisib in PIK3CA driven vascular anomalies, with a majority of evaluated patients meeting volumetric response criteria and reporting symptom relief at 12 weeks. See our latest analysis for Relay Therapeutics. The recent zovegalisib data sits alongside a year of strong price momentum, with Relay Therapeutics’ 30 day share price return of 10.46% and year to date share price return of 71.76% contributing to a very large 1 year...

Upcoming earnings put Annaly Capital Management (NLY) in focus Investor attention around Annaly Capital Management (NLY) is building ahead of its upcoming earnings release, with expectations for an earnings per share increase and recent analyst estimate revisions pointing to a healthier business outlook. See our latest analysis for Annaly Capital Management. At a share price of US$21.85, Annaly Capital Management has seen its 1-day share price return of 1.16% and 7-day share price return of...

Williams Companies stock snapshot after recent performance Williams Companies (WMB) has pulled back recently, with the stock down about 2% over the past day, 9% over the past week, and 5% over the past month, despite positive longer term returns. See our latest analysis for Williams Companies. That pullback comes after a strong run, with the share price still up 17.32% year to date and a 1 year total shareholder return of 20.33%. This suggests recent momentum has cooled even as longer term...

Recent share performance and business snapshot Without a clear single news headline driving ePlus (PLUS), investors are looking at the stock through its recent performance, business mix, and growth metrics to understand what might be priced in. The share price closed at US$82.09, with the stock down 7.4% over the past day, 3.8% over the past week, and 3.7% over the past month, while up 2.8% over the past 3 months. Over longer horizons, ePlus has delivered a 17.1% total return over the past...